Please login to the form below

Not currently logged in
Email:
Password:

Ranbaxy launches generic version of AZ drug

Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US
Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US.

Prilosec, a treatment for conditions caused by excess stomach acid, was originally developed and marketed by AZ and experienced sales in the US of $204.2m, according to IMS data cited by Ranbaxy. Under the terms of the new agreement Ranbaxy Pharmaceuticals - a wholly owned subsidiary of India's largest pharma company, Ranbaxy Laboratories - will begin manufacturing the drug using its generic name, omeprazole.

"We welcome the opportunity to market an authorised generic of omeprazole 40mg capsules that will be commercialised immediately to all classes of trade in the US healthcare system under the Ranbaxy label," said Jim Meehan, vice-president of sales and distribution for RPI.

RPI is based in Florida and markets products to the US healthcare system.

28th July 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics